Clue 1: Orient yourself
Who experiences the benefits and risks?
Use the labels and the picture's left-to-right, near-to-far, or before-and-after order. Name only what you can point to.
The question
Who experiences the benefits and risks?
Why it matters: Genetic results can change family counseling and research decisions. They must be interpreted without turning risk into destiny or an uncertain variant into a diagnosis. Today you practice the professional reasoning behind that work: An ethical decision weighs benefit, harm, autonomy, heritability, access, and alternatives before technical possibility.
On your WebXam
Applying bioethical principles to weigh somatic vs germline intervention
For life
Having a gene is not the same as using it.
Principle: Having it is not using it
Five principles we return to
Having it is not using it
Same instructions, different switches
Same look, different cause
Change one thing and watch
Boss or doorman?
Decides the result or only allows it
Held down, not gone
Remove the brake and it returns
Many roads, one ending
One result can begin many ways
Try the everyday version first
A community bridge decision needs more than an engineer
A bridge plan affects safety, cost, access, land, and the people who use it. Engineers supply evidence, while the community must also weigh values and tradeoffs.
Do not jump to the biology yet. Treat the picture as a small system. Track its parts, follow one change at a time, and keep more than one explanation open until the picture supplies a way to separate them.
Clue 2: Trace one change
Which voices are missing if only engineers decide?
Follow one object, stage, or path. Point to the first place where the situation changes instead of jumping to the ending.
Clue 3: Keep the cause open
How does an irreversible choice change the process?
List more than one explanation that still fits. Name the extra observation that would help you separate those possibilities.
Now inspect the illustration
Work from the visible evidence. A useful answer names the part of the picture that supports it and leaves unknown causes open.
- 1Who experiences the benefits and risks?
- 2Which voices are missing if only engineers decide?
- 3How does an irreversible choice change the process?
Tier 1 check
Finish with the everyday model
Use the everyday picture to answer today's question in plain words: Who experiences the benefits and risks?
You can complete today's required check without opening the technical details below.
Ready for the real names? Optional tier 2
Technical rules and limits
Rule 1: Separate somatic from germline effects.
Rule 2: Compare intervention with effective existing care.
Rule 3: Include affected communities and equity in governance.
Where the analogy stops: Human genetic intervention has deeper identity and heritability questions than infrastructure planning.
Carry the previous idea forward
Gene editing, pathway rescue, and gene-dosage modulation are different strategies with different targets and risks.
Today's technical takeaway
An ethical decision weighs benefit, harm, autonomy, heritability, access, and alternatives before technical possibility.
Now map the same rules onto biology
Apply an ethics matrix to a future cleft intervention
Bridge benefit
Potential health or functional benefit
Irreversible design
Germline and long-term effects
Community table
Patients, families, clinicians, advocates, and public governance
Educational illustration, not a clinical photograph or diagnostic result. Use the labeled evidence cards and claim ceiling.
Mateo's case file: evidence supplied in this lesson
GEN19-E1
Cleft lip and palate already have effective multidisciplinary treatments, though access is unequal.
Why it matters: A genetic intervention must be compared with real alternatives.
GEN19-E2
Germline editing could affect future generations who cannot consent.
Why it matters: Heritability changes the ethical stakes.
GEN19-E3
Access to cleft care and new technology is uneven.
Why it matters: Equity is part of benefit and harm.
Make the clinical decision
You are chairing a future hospital ethics panel.
A proposed germline intervention may reduce cleft risk but has uncertain off-target effects and high cost.
APause approval and require stronger safety, governance, community input, and access planning.
BApprove because editing is technically possible.
CExclude people born with clefts from the discussion.
Choose the panel decision and cite two ethical dimensions.
Evidence required
GEN19-E1 + GEN19-E2 Claim ceiling
You may reason from the supplied case. You may not claim one universal moral answer for every family or future technology.Go deeper Optional tier 3
Everything required for today is above. Open these only if you want the explainer, source trail, or download files.
The everyday model and Tier 1 check are the complete required path for this lesson.
Use these checks to keep your place. They are not turned in through the portal.
Check off as you finish
- Worked through the everyday picture and answered its three questions.
- Completed the Tier 1 check in plain words.
Turn in: Genetics lesson 19: Should We, and Who Decides?
Go to Schoology to turn this in.
Submit one PDF. Put your first and last name in the document header. Name the file: FirstName LastName - Assignment Title - YYYY-MM-DD.pdf.
Open Schoology PDF upload helpIf you cannot get in, see Mr. Mendoza. Do not skip the work.
Optional legacy technical materials Open only if you want the original notes, vocabulary, artifact, and CER work
Before this page, you should know
- treats disease by adding, correcting, or adjusting genes or their products.
- nudges a pathway up or down without rewriting DNA; a Wnt agonist rescued Pax9-null mouse palates in utero.
If not, review
Today's new idea is only
A sound bioethical position weighs benefit, risk, consent, AND fair access together, and the sharpest line is (not inherited) versus (inherited, broadly restricted) editing.
Goal: Use a structured reasoning model to weigh versus for clefting against benefit, risk, equity, and consent, and reach a defended position.
Know by the end
- Bioethics is structured reasoning about what we should do in medicine, not just what we can do.
- A edit changes only the patient and is not inherited; a edit changes , egg, or sperm and is inherited by all descendants, which is why is broadly restricted.
- Beneficence weighs benefit against harm, and because CL/P is already treatable by surgery, the bar for accepting experimental risk is high.
- Equity matters: risk variants were studied mostly in European groups, and some high-incidence communities (AI-AN) face documented barriers to ordinary care.
1
Four ideas for the cleft case
Model start: Bioethics is structured reasoning about what we should do, not just what we can do. Four ideas guide the case.
- ____ is the right of a person (or their parents, for a child) to make informed choices about their own body, which is why is troubling: future generations cannot consent.
- ____ (do good), weighed against harm, asks whether the benefit outweighs the risk; because CL/P is already treatable, the bar for experimental risk is higher.
- ____ asks who actually gets access, since a therapy offered only to the wealthy could widen the existing gap.
2
The sharpest line
- ____ editing changes only the patient and is not inherited, so it is ethically more accepted.
- ____ editing changes , egg, or sperm, is inherited by all descendants, and is broadly restricted or prohibited.
Everything you need for today is on this page. These links are optional.
What to read
Read the short plain-language explanation written for this lesson. Plain-language explainer for this lesson
Why this source matters
This explanation gives you the background for today's idea without making you decode a research paper: A sound bioethical position weighs benefit, risk, consent, AND fair access together, and the sharpest line is (not inherited) versus (inherited, broadly restricted) editing.
Words to unlock first
Reading moves
- Skim the title and abstract first to get the gist.
- Circle the one sentence that states the main claim.
- Box the evidence the authors give for that claim.
- Mark one sentence that confuses you, and move on.
Stop point
Stop after the final 'Use it now' section. The research citations are available separately for advanced readers.
Your output
Write one claim-evidence sentence: state the main idea, then name the example or evidence that supports it.
Where this fits
Tested on (Ohio WebXam)
Genetics of Disease · 072130
PLTW lesson
MI · Genetics domain · Bioethics of genetic medicine; patient rights
WebXam domain
Molecular and Genetic Technology
Evidence to produce
Take a defended position. In five to seven sentences answer the driving question for this case specifically: would you support a somatic intervention, a germline intervention, or neither, given that clefting is already surgically treatable? Use at least two of the four ideas (autonomy, beneficence, somatic vs germline, equity) by name, and cite the equity evidence. There is no single correct answer; you are graded on reasoning.
Lab / skill
Medical Interventions (MI) · Biomedical Innovations (BI)
Everything required for today's decision is already in the case file and plain-language explainer. The links below are original papers and database records for teachers and advanced readers, not assigned student reading.
- Babai & Irving 2023, Orofacial Clefts: management and surgical treatment (Genes)
- Wolfswinkel et al. 2022, AI-AN access to comprehensive cleft treatment (Cleft Palate Craniofac J)
- Kousa et al. 2017, somatic vs germline framing in IRF6 rescue (Dev Dyn)
- Leslie et al. 2012, IRF6 penetrance and counseling context (Genet Med)
- Claim: State your position on genetic intervention for this case (, , or neither).
- Evidence: Cite one fact from today's models, for example that ____ communities face documented barriers to comprehensive care.
- Reasoning: Explain your position using at least one named ethical idea (autonomy, beneficence, vs , or ____).
How this is graded (rubric)
For: Take a defended position. In five to seven sentences answer the driving question for this case specifically: would you support a somatic intervention, a germline intervention, or neither, given that clefting is already surgically treatable? Use at least two of the four ideas (autonomy, beneficence, somatic vs germline, equity) by name, and cite the equity evidence. There is no single correct answer; you are graded on reasoning.
| Criterion | Proficient | Developing | Beginning |
|---|---|---|---|
| Complete | Every required part of the artifact is present and filled in. | Most parts are present, but one is missing or left blank. | Several parts are missing. |
| Accurate | The science and data are correct and match the evidence. | Mostly correct, with a small factual slip. | Key science or data is wrong. |
| Scientific reasoning (CER) | States a claim, backs it with specific evidence, and explains the reasoning. | Has a claim and evidence, but the reasoning is thin or missing. | Gives an answer with no evidence or reasoning. |
| Professional communication | Clear, organized, and labeled the way a clinician or scientist would write it. | Readable but disorganized or missing labels. | Hard to follow. |
| Submitted | Turned in through the route named under Submit here and confirmed. | Turned in, but in the wrong place or unconfirmed. | Not turned in. |
How the model answer scores against this rubric
- CompleteProficient: Nothing is left blank: the model fills every part of "Take a defended position. In five to seven sentences answer the driving question for this case specifically: would you support a somatic intervention, a germline intervention, or neither, given that clefting is already surgically treatable? Use at least two of the four ideas (autonomy, beneficence, somatic vs germline, equity) by name, and cite the equity evidence. There is no single correct answer; you are graded on reasoning.".
- AccurateProficient: Every number and claim matches the case evidence.
- Scientific reasoning (CER)Proficient: It names a claim, cites the specific evidence, and explains the reasoning, not just the answer.
- Professional communicationProficient: It is organized and labeled like a real chart note.
- SubmittedProficient: It would be attached to your class form or handed in, and confirmed.
What's next: We have now followed the gene from the first clue all the way to treatment and the ethics of treatment. Nothing is left to add: the only task remaining is to put the whole story together. What is Mateo's complete genetic story, start to finish? We assemble it next.